Trial intelligence / Profile preview

Preventive analgesic effect of etoricoxib vs celecoxib after third molar surgery

2020-001638-37Phase 4Active

Sponsor
Semmelweis University Department of Oro-Maxillofacial Surgery and Stomatology
Start
Jun 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Etoricoxib arm with Celecoxib arm (2 arms). Primary endpoint: Postoperative pain intensity on VAS. Started Jun 2020; status: active.

02

Drugs

etoricoxibcelecoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2020-001638-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-001638-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call